Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Other Accumulated Expenses: 2022-2023

  • Lexeo Therapeutics' Other Accumulated Expenses was N/A to $182,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $182,000, marking a year-over-year change of. This contributed to the annual value of $240,000 for FY2022, which is N/A change from last year.
  • Latest data reveals that Lexeo Therapeutics reported Other Accumulated Expenses of $182,000 as of Q3 2023, which was down 24.17% from $240,000 recorded in Q4 2022.
  • In the past 5 years, Lexeo Therapeutics' Other Accumulated Expenses registered a high of $240,000 during Q4 2022, and its lowest value of $182,000 during Q3 2023.
  • Its 2-year average for Other Accumulated Expenses is $211,000, with a median of $211,000 in 2022.